Kenvue sells consumer health products, including pain relievers, skin care, oral care and baby care items sold worldwide. It last closed at $19.31 on Oct 30, down 1.28% on the day. The next earnings report for KVUE is expected around Tue, Feb 16, 2027, after the close. For the quarter ended Sep 2026, KVUE reported EPS of $0.22 on revenue of $3.89B, with revenue up 3.2% from a year ago. Over its last 8 reports the stock moved an average of 3.7% the session after earnings. Over the last 12 months KVUE insiders bought $111.0M of stock on the open market and sold $747K, according to SEC Form 4 filings.
AI Auto Pilots
Is KVUE in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold KVUE.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on KVUEStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
KVUE · as of the Oct 30 close · updated each morning
Uptrend
The stock is 3% above its 20 day and 5% above its 50 day average. It is 6% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 60). The nearest support is the Pivot S1 at $19.01, and the nearest resistance the swing high (Jul 17) at $19.36.
Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityNormal, 2.0%/day
Key levels
$20.1352 week high+4.2%
$19.81Pivot R1+2.6%
$19.50Pivot+1.0%
$19.36Swing high (Jul 17)+0.3%
$19.31Last close
$19.01Pivot S1−1.6%
$18.77Swing low (Jul 23)−2.8%
$18.70100 day average−3.2%
$18.6420 day average−3.5%
$18.4150 day average−4.7%
$18.19200 day average−5.8%
$14.0252 week low−27.4%
Indicators
RSI (14)
59.98
Middle of its range
Neutral
MACD
0.40
Above its signal line
Bullish
Stochastic
78.3
Middle of its range
Neutral
ADX (14)
34.3
Trending up
Williams %R
-28.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
76.6
Oversold below −100, overbought above 100
Neutral
Rate of change
+2.1%
Change over 10 sessions
Bullish
ATR (14)
$0.38
Typical daily range, 2.0% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumStrong
StretchNormal
VolatilityNormal, 4.4%/day
Key levels
$20.1352 week high+4.2%
$19.81Pivot R1+2.6%
$19.50Pivot+1.0%
$19.36Swing high (Jul 17)+0.3%
$19.31Last close
$19.01Pivot S1−1.6%
$18.77Swing low (Jul 23)−2.8%
$18.70100 day average−3.2%
$18.6420 day average−3.5%
$18.4150 day average−4.7%
$18.19200 day average−5.8%
$14.0252 week low−27.4%
Indicators
RSI (14)
57.69
Middle of its range
Neutral
MACD
0.14
Above its signal line
Bullish
Stochastic
72.9
Middle of its range
Neutral
ADX (14)
18.9
No clear trend
Williams %R
-25.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
84.2
Oversold below −100, overbought above 100
Neutral
Rate of change
+1.3%
Change over 10 sessions
Bullish
ATR (14)
$0.86
Typical daily range, 4.5% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Below
MA 200–
What happened before, for KVUE
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how KVUE did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow KVUE usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for KVUEHow many large options trades hit KVUE, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in KVUE in the last 90 days.
From SEC Form 4 filings by KVUE's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.
From the company's 10-Q filed Oct 30, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether KVUE is in one of them and how their past KVUE trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Kenvue
Kenvue is a consumer health company based in Summit, New Jersey. It makes over the counter medicines such as pain relievers and allergy treatments, along with skin and hair care, oral care, baby care, wound care and menstrual products. Well known brands include Tylenol, Listerine, Neutrogena and Johnson's. Its products are sold to consumers in many countries, and healthcare professionals help shape product development.